Crossmark

A novel hybrid model for predicting tertiary lymphoid structures and targeted immunotherapy outcomes in hepatocellular carcinoma: a multicenter retrospective study

Crossref DOI link: https://doi.org/10.1007/s00330-024-11255-9

Published Online: 2024-12-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Yiman

Li, Xiaofeng

Xiao, Xixi

Cheng, Jie

Li, Qingrui

Liu, Chen

Cai, Ping

Chen, Wei

Zhang, Huarong

Li, Xiaoming https://orcid.org/0000-0002-7229-5915
Funding

Funding for this research was provided by:

Program of the National Natural Science Foundation of Chongqing (CSTB2022NSCQMSX1371)
License Information

Text and Data Mining valid from 2024-12-10

Version of Record valid from 2024-12-10
More Information

Article History

Received: 25 July 2024

Revised: 29 September 2024

Accepted: 24 November 2024

First Online: 10 December 2024

Compliance with ethical standards

:

: The scientific guarantor of this publication is Dr. Xiaoming Li.

: All authors of this manuscript have no competing interests to declare.

: No complex statistical methods were necessary for this paper.

: Written informed consent was waived by the Institutional Review Board.

: Institutional Review Board approval was obtained.

: Not applicable.

:

Document is current

Any future updates will be listed below